Skip to Content

WPI 2281 (Zolpidem tartrate extended-release 6.25 mg)

Pill imprint WPI 2281 has been identified as Zolpidem tartrate extended-release 6.25 mg.

Zolpidem is used in the treatment of insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Risk cannot be ruled out during pregnancy. Zolpidem 6.25 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Zolpidem tartrate extended-release
Imprint:
WPI 2281
Strength:
6.25 mg
Color:
Green
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous anxiolytics, sedatives and hypnotics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
4 - Some potential for abuse
Manufacturer:
Watson Laboratories, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide